Literature DB >> 32629043

Where there's smoke, there's fire: Cannabis, P2RX7 and inflammatory pathways intersect to increase psychosis susceptibility.

David R Goldsmith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32629043      PMCID： PMC8195265          DOI： 10.1016/j.bbi.2020.06.031

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN： 0889-1591            Impact factor:   7.217


× No keyword cloud information.
  10 in total

1.  Can anti-inflammatory strategies light up the dim depression pipeline?

Authors:  Megan Cully
Journal:  Nat Rev Drug Discov       Date:  2020-03-18       Impact factor: 84.694

Review 2.  Gene-environment interplay in the etiology of psychosis.

Authors:  Alyson Zwicker; Eileen M Denovan-Wright; Rudolf Uher
Journal:  Psychol Med       Date:  2018-01-15       Impact factor: 7.723

Review 3.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

4.  Genome scan for susceptibility loci for schizophrenia and bipolar disorder.

Authors:  Ursula Bailer; Friedrich Leisch; Kurt Meszaros; Elisabeth Lenzinger; Ulrike Willinger; Rainer Strobl; Angela Heiden; Christian Gebhardt; Elisabeth Döge; Karoline Fuchs; Werner Sieghart; Siegfried Kasper; Kurt Hornik; Harald N Aschauer
Journal:  Biol Psychiatry       Date:  2002-07-01       Impact factor: 13.382

5.  Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene.

Authors:  Marco P Boks; Yujie He; Chris D Schubart; Willemijn van Gastel; Laurent Elkrief; Guillaume Huguet; Kristel van Eijk; Christiaan H Vinkers; René S Kahn; Tomás Paus; Patricia Conrod; Elly M Hol; Lot D de Witte
Journal:  Brain Behav Immun       Date:  2020-04-21       Impact factor: 7.217

Review 6.  The microglial ATP-gated ion channel P2X7 as a CNS drug target.

Authors:  Anindya Bhattacharya; Knut Biber
Journal:  Glia       Date:  2016-05-24       Impact factor: 7.452

7.  Cannabis use and risk of schizophrenia: a Mendelian randomization study.

Authors:  J Vaucher; B J Keating; A M Lasserre; W Gan; D M Lyall; J Ward; D J Smith; J P Pell; N Sattar; G Paré; M V Holmes
Journal:  Mol Psychiatry       Date:  2017-01-24       Impact factor: 15.992

8.  C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation.

Authors:  Elham Asgari; Gaelle Le Friec; Hidekazu Yamamoto; Esperanza Perucha; Steven S Sacks; Jörg Köhl; H Terence Cook; Claudia Kemper
Journal:  Blood       Date:  2013-07-22       Impact factor: 22.113

9.  Schizophrenia risk from complex variation of complement component 4.

Authors:  Aswin Sekar; Allison R Bialas; Heather de Rivera; Avery Davis; Timothy R Hammond; Nolan Kamitaki; Katherine Tooley; Jessy Presumey; Matthew Baum; Vanessa Van Doren; Giulio Genovese; Samuel A Rose; Robert E Handsaker; Mark J Daly; Michael C Carroll; Beth Stevens; Steven A McCarroll
Journal:  Nature       Date:  2016-01-27       Impact factor: 49.962

10.  Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis.

Authors:  Guy Hindley; Katherine Beck; Faith Borgan; Cedric E Ginestet; Robert McCutcheon; Daniel Kleinloog; Suhas Ganesh; Rajiv Radhakrishnan; Deepak Cyril D'Souza; Oliver D Howes
Journal:  Lancet Psychiatry       Date:  2020-03-17       Impact factor: 77.056
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.